Federated Hermes’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-777
| Closed | -$4K | – | 2279 |
|
|
2019
Q1 | $4K | Hold |
777
| – | – | ﹤0.01% | 2020 |
|
|
2018
Q4 | $3K | Hold |
777
| – | – | ﹤0.01% | 2066 |
|
|
2018
Q3 | $8K | Hold |
777
| – | – | ﹤0.01% | 1997 |
|
|
2018
Q2 | $6K | Hold |
777
| – | – | ﹤0.01% | 2003 |
|
|
2018
Q1 | $5K | Sell |
777
-391
| -33% | -$3.23K | ﹤0.01% | 1980 |
|
|
2017
Q4 | $11K | Hold |
1,168
| – | – | ﹤0.01% | 1874 |
|
|
2017
Q3 | $10K | Sell |
1,168
-1,338
| -53% | -$13.8K | ﹤0.01% | 1853 |
|
|
2017
Q2 | $32K | Sell |
2,506
-1,466
| -37% | -$17.3K | ﹤0.01% | 1720 |
|
|
2017
Q1 | $42K | Sell |
3,972
-42,524
| -91% | -$453K | ﹤0.01% | 1670 |
|
|
2016
Q4 | $428K | Sell |
46,496
-58,835
| -56% | -$665K | ﹤0.01% | 1352 |
|
|
2016
Q3 | $1.24M | Sell |
105,331
-33,312
| -24% | -$506K | ﹤0.01% | 1036 |
|
|
2016
Q2 | $1.79M | Buy |
138,643
+29,952
| +28% | +$437K | 0.01% | 886 |
|
|
2016
Q1 | $1.74M | Buy |
108,691
+94,242
| +652% | +$1.79M | 0.01% | 890 |
|
|
2015
Q4 | $413K | Buy |
14,449
+14,444
| +288,880% | +$400K | ﹤0.01% | 1340 |
|
|
2015
Q3 | $1K | Buy |
+5
| New | +$184 | ﹤0.01% | 1943 |
|
|
2015
Q2 | – | Sell |
-118,000
| Closed | -$3.43M | – | 2130 |
|
|
2015
Q1 | $3.43M | Buy |
+118,000
| New | +$3.12M | 0.01% | 743 |
|
|
2014
Q2 | – | Sell |
-38,068
| Closed | -$789K | – | 2026 |
|
|
2014
Q1 | $789K | Sell |
38,068
-11,438
| -23% | -$227K | ﹤0.01% | 1232 |
|
|
2013
Q4 | $639K | Buy |
+49,506
| New | +$687K | ﹤0.01% | 1266 |
|
Other funds holding INSY
WS
Federated Hermes's INSY Position: Q2 2019 in Review
Federated Hermes sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 777 shares — an estimated $4K sold.
Federated Hermes first reported a position in INSY in Q4 2013 and held it in 18 quarters. The position peaked at $3.43M in Q1 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Federated Hermes reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Federated Hermes sold 777 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $4K.
- Federated Hermes first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 18 quarters.
- Federated Hermes's Insys Therapeutics, Inc. position peaked at $3.43M in Q1 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.